Takeda Files New JPY 240B Shelf Registration for LTIP Shares; 1.1% Dilution

Takeda Pharmaceutical Co Ltd announced the withdrawal of an old shelf registration statement and the filing of a new one in Japan. This new filing is for the issuance of new shares or disposition of treasury shares, up to JPY 240 billion, to facilitate its Long Term Incentive Plan (LTIP). The scheduled issue period is from June 9, 2026, to June 8, 2027, and the company expects approximately 1.1% share dilution for the fiscal year ending March 31, 2027, due to the LTIP.